Phase II study of carfilzomib (CFZ) in combination with current agents for relapsed and refractory multiple myeloma (RRMM)
| Autor: | Jackie Szymonifka, Saad Z. Usmani, Yazan Alsayed, Bart Barlogie, Susan Panozzo, Bijay Nair, John Crowley, Sarah Waheed, Rachael Sexton |
|---|---|
| Rok vydání: | 2011 |
| Předmět: | |
| Zdroj: | Journal of Clinical Oncology. 29:8028-8028 |
| ISSN: | 1527-7755 0732-183X |
| Popis: | 8028 Background: CFZ is an epoxomicin derivative with ability to irreversibly inhibit proteosomes, with clinical activity. It has been shown in preclinical and early clinical studies to have activi... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|